SCHEMBL17012199

SCHEMBL17012199

c1ccc2c(c1)-c1cccc3c(-c4ccc(N(c5ccncc5)c5ccncc5)cc4)ccc-2c13

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRHBP P24387 1/20 0.40
CRHR2 Q13324 1/20 0.40
KEAP1 Q14145 1/20 0.40
NFE2L2 Q16236 1/20 0.40
TNF P01375 2/20 0.38
PIK3CD O00329 1/20 0.37
MAPK1 P28482 3/20 0.35
HSD17B10 Q99714 3/20 0.35
ALDH1A1 P00352 2/20 0.35
HPGD P15428 2/20 0.35
TSHR P16473 1/20 0.35
CASP1 P29466 1/20 0.35
HIF1A Q16665 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
IMPDH2 P12268 2/20 0.35
MAPK11 Q15759 1/20 0.35
MAPK14 Q16539 1/20 0.35
MAPT P10636 3/20 0.34
SMN1; SMN2 Q16637 3/20 0.34
PABPC1 P11940 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17012373 1.00 CRHBP (0.40) CRHBPCRHR2KEAP1NFE2L2TNF
SCHEMBL16484543 0.97 TNF (0.40) CRHBPCRHR2KEAP1NFE2L2TNF
SCHEMBL16484617 0.96 TNF (0.42) CRHBPCRHR2KEAP1NFE2L2TNF
SCHEMBL16484607 0.95 MAPT (0.40) CRHBPCRHR2KEAP1NFE2L2TNF
SCHEMBL16485354 0.95 MAPT (0.40) CRHBPCRHR2KEAP1NFE2L2TNF
SCHEMBL16485350 0.93 PIK3CA (0.40) CRHBPCRHR2KEAP1NFE2L2TNF
SCHEMBL17012202 0.91 CYP11B1 (0.40) CRHBPCRHR2KEAP1NFE2L2TNF
SCHEMBL17012318 0.89 MAPK9 (0.40) CRHBPCRHR2KEAP1NFE2L2TNF
SCHEMBL16485347 0.88 TNF (0.41) TNFMAPK1HSD17B10ALDH1A1HPGD
SCHEMBL16484086 0.88 PIK3CA (0.37) CRHBPCRHR2KEAP1NFE2L2TNF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2907803-B1 FLUORANTHENE DERIVATIVE, LUMINESCENT ELEMENT MATERIAL CONTAINING SAME, AND LUMINESCENT ELEMENT TORAY INDUSTRIES (JP) 2021-08-18 EP disclosed
US-9935273-B2 Fluoranthene derivative, light-emitting device material containing same, and light-emitting device TORAY INDUSTRIES, INC. (JP) 2018-04-03 US disclosed
US-20150280139-A1 FLUORANTHENE DERIVATIVE, LIGHT-EMITTING DEVICE MATERIAL CONTAINING SAME, AND LIGHT-EMITTING DEVICE TORAY INDUSTRIES, INC. (JP) 2015-10-01 US disclosed
US-20150280139-A1 FLUORANTHENE DERIVATIVE, LIGHT-EMITTING DEVICE MATERIAL CONTAINING SAME, AND LIGHT-EMITTING DEVICE TORAY INDUSTRIES, INC. (JP) 2015-10-01 US disclosed
EP-2907803-A1 FLUORANTHENE DERIVATIVE, LUMINESCENT ELEMENT MATERIAL CONTAINING SAME, AND LUMINESCENT ELEMENT Toray Industries, Inc. (JP) 2015-08-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150280139-A1 FLUORANTHENE DERIVATIVE, LIGHT-EMITTING DEVICE MATERIAL CONTAINING SAME, AND LIGHT-EMITTING DEVICE FMNL1, AFF2, LEF1 CRHBP 4822/4885CRHR2 4829/4885KEAP1 1487/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.